Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
48303-2 Brilliant black BN leukotriene release MCnc WBC Pt Qn     ACTIVE Brilliant black BN triggered leukotriene release [Mass/volume] by Leukocytes   MIN DefinitionDescription     pg/mL sLT             ALLERGY   48303-2         Both       0 Brilliant black BN LR-mCnc       N   Allergen; Allergens; ALLERGY TESTING; CAST; Leukocytes; Level; LR; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells 2.7 2.21               pg/mL{sLT}       0
48304-0 Glutamate leukotriene release MCnc WBC Pt Qn     ACTIVE Glutamate triggered leukotriene release [Mass/volume] by Leukocytes   MIN DefinitionDescription     pg/mL sLT             ALLERGY   48304-0         Both       0 Glutamate LR-mCnc       N   Allergen; Allergens; ALLERGY TESTING; c707; CAST; Glu; Glutamic acid; Leukocytes; Level; LR; Mass Concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WBCs; White blood cells 2.7 2.21               pg/mL{sLT}       0
48305-7 Coproporphyrin 1/Creatinine MRto Urine Pt Qn     ACTIVE Coproporphyrin 1/Creatinine [Mass Ratio] in Urine   MIN DefinitionDescription     ug/g creatinine             CHEM   48305-7         Both       0 Copro1/Creat Ur       N   Chemistry; Copro; Copro1; Coproporph; Coproporphyrin I; Coproporphyrins; CR; Crea; Creat; i; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; Tetracarboxyl porphyrin; Tetracarboxylporphyrin; Tetracarboxylporphyrins; Tetracarboxyporphyrin; UA; UCr; UR; Urn 2.73 2.21               ug/g{creat}       0
48306-5 Coproporphyrin 3/Creatinine MRto Urine Pt Qn     ACTIVE Coproporphyrin 3/Creatinine [Mass Ratio] in Urine   MIN DefinitionDescription     ug/g creatinine             CHEM   48306-5         Both       0 Copro3/Creat Ur       N   Chemistry; Copro; Copro3; Coproporph; Coproporphyrin III; Coproporphyrins; CR; Crea; Creat; III; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; Tetracarboxyl porphyrin; Tetracarboxylporphyrin; Tetracarboxylporphyrins; Tetracarboxyporphyrin; UA; UCr; UR; Urn 2.73 2.21               ug/g{creat}       0
48307-3 Didanosine MCnc Ser/Plas Pt Qn     ACTIVE Didanosine [Mass/volume] in Serum or Plasma   MIN DefinitionDescription     ug/mL             DRUG/TOX   48307-3         Both       0 Didanosine SerPl-mCnc       N   ddI; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Videx 2.7 2.21               ug/mL       0
48308-1 DNA double strand Ab ACnc Body fld Pt Qn Farr   ACTIVE DNA double strand Ab [Units/volume] in Body fluid by Farr method   MIN DefinitionDescription     IU/mL             SERO   48308-1   Farr     Both       0 dsDNA Ab Fld Farr-aCnc       N   ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Deoxyribonucleic acid; DNA binding ab; ds; dsDNA; dsnda; Fl; Fld; FLU; Fluid; Native DNA; N-DNA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Stranded; Strnd 2.7 2.21               [IU]/mL       0
48309-9 BK virus DNA NCnc XXX Pt Qn Probe.amp.tar   ACTIVE BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection   MIN DefinitionDescription     copies/mL             MICRO   48309-9   Probe.amp.tar     Both       0 BKV DNA # Spec NAA+probe       N   #; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; Amplif; Amplification; Amplified; BKV; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Viral load 2.73 2.21               {copies}/mL       0
4831-4 HLA-B40 PrThr Bld/Tiss Pt Ord     ACTIVE HLA-B40 [Presence]   MIN DefinitionDescription                   HLA   4831-4         Observation       0 HLA-B40 Ql           Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue 2.73 1                     This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld' to 'Bld/Tiss' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
48310-7 Influenza virus A PrThr XXX Pt Ord Organism specific culture   ACTIVE Influenza virus A [Presence] in Specimen by Organism specific culture   MIN DefinitionDescription                   MICRO   48310-7   Organism specific culture     Both       0 FLUAV Spec Ql Cult       N   Avian influenza; Bird flu; C&S; Cult; Cultures; FLUA; FLUAV; FLUV; Fowl plague; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified 2.73 2.21                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
48311-5 Lysosomal enzymes screen Prid Bld Pt Nom     ACTIVE Lysosomal enzymes screen [Identifier] in Blood   MIN DefinitionDescription                   CHEM   48311-5         Both       0 Lysosomal Enzymes Scn Bld       N   Blood; Chemistry; Enz; Enzyme; Identity or presence; Lysosomal Enzymes Scn; Nominal; Point in time; Random; Scn; Scr; Scrn; WB; Whole blood 2.21 2.21                       0
48312-3 Yersinia enterocolitica O:5 Ab Titr Ser Pt SemiQn Aggl   ACTIVE Yersinia enterocolitica O:5 Ab [Titer] in Serum by Agglutination   MAJ DefinitionDescription     titer             MICRO   48312-3   Aggl     Both       0 Y entero O:5 Ab Titr Ser Aggl       N   ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr; Y entero O:5; Y enterocol; Y enterocolitica 2.75 2.21               {titer}     Changed O5 to O:5 based on currently recommended nomenclature for the Yersinia enterocolitica serogroups [PMID: 22019131] 0
48313-1 Yersinia enterocolitica O:9 Ab Titr Ser Pt SemiQn Aggl   ACTIVE Yersinia enterocolitica O:9 Ab [Titer] in Serum by Agglutination   MAJ DefinitionDescription     titer             MICRO   48313-1   Aggl     Both       0 Y entero O:9 Ab Titr Ser Aggl       N   ABS; Aby; Agg; Agglut; Agglutination; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr; Y entero O:9; Y enterocol; Y enterocolitica 2.75 2.21               {titer}     Changed zero to O in component; Changed O9 to O:9 based on currently recommended nomenclature for the Yersinia enterocolitica serogroups [PMID: 22019131] 0
48314-9 Leishmania mexicana Ab.IgG Titr Ser Pt SemiQn IF   ACTIVE Leishmania mexicana IgG Ab [Titer] in Serum by Immunofluorescence   MAJ DefinitionDescription     titer             MICRO   48314-9   IF     Both       0 L mexicana IgG Titr Ser IF       N   ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; L mexicana; Leishmaniasis; Leishmaniosis; Microbiology; Point in time; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr 2.75 2.21               {titer}       0
48315-6 Leishmania mexicana Ab.IgM Titr Ser Pt SemiQn IF   ACTIVE Leishmania mexicana IgM Ab [Titer] in Serum by Immunofluorescence   MAJ DefinitionDescription     titer             MICRO   48315-6   IF     Both       0 L mexicana IgM Titr Ser IF       N   ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; L mexicana; Leishmaniasis; Leishmaniosis; Microbiology; Point in time; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr 2.75 2.21               {titer}       0
48316-4 Leishmania tropica Ab.IgG Titr Ser Pt SemiQn IF   ACTIVE Leishmania tropica IgG Ab [Titer] in Serum by Immunofluorescence   MAJ DefinitionDescription     titer             MICRO   48316-4   IF     Both       0 L tropica IgG Titr Ser IF       N   ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; L tropica; L tropicalis; Leishmaniasis; Leishmaniosis; Microbiology; Point in time; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr 2.75 2.21               {titer}       0
48317-2 Leishmania tropica Ab.IgM Titr Ser Pt SemiQn IF   ACTIVE Leishmania tropica IgM Ab [Titer] in Serum by Immunofluorescence   MAJ DefinitionDescription     titer             MICRO   48317-2   IF     Both       0 L tropica IgM Titr Ser IF       N   ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; L tropica; L tropicalis; Leishmaniasis; Leishmaniosis; Microbiology; Point in time; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr 2.75 2.21               {titer}       0
48318-0 Cat hair+Cat epithelium Ab.IgE.RAST class ACnc Ser Pt Ord     DEPRECATED Deprecated Cat hair + Cat dander IgE Ab RAST class in Serum   DEL DefinitionDescription                   ALLERGY   48318-0         Both       0 Deprecated Cat Hair+Epith IgE RAST Ql       N   ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Epithelia; Feline; Felis domesticus; IgE RAST; Immune globulin E; Immunoglobulin E; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Serum; SR 2.36 2.21       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
48319-8 glipiZIDE PrThr XXX Pt Ord     ACTIVE glipiZIDE [Presence] in Specimen   MIN DefinitionDescription                   DRUG/TOX   48319-8         Both       0 glipiZIDE Spec Ql       N   DRUG/TOXICOLOGY; Drugs; Glucotrol; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified 2.69 2.21                     The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
4832-2 HLA-B44(12) PrThr Bld/Tiss^Donor Pt Ord     ACTIVE HLA-B44(12) [Presence] in Donor   MAJ DefinitionDescription                   HLA   4832-2         Observation       0 HLA-B44(12) Donr Ql           Blood; Donr; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue 2.56 1                     This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld^donor' to 'Bld/Tiss^donor' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
48320-6 glyBURIDE PrThr XXX Pt Ord     ACTIVE glyBURIDE [Presence] in Specimen   MIN DefinitionDescription                   DRUG/TOX   48320-6         Both       0 glyBURIDE Spec Ql       N   DiaBeta; DRUG/TOXICOLOGY; Drugs; Glynase; Micronase; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified 2.69 2.21                     The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
48321-4 TOLBUTamide PrThr XXX Pt Ord     ACTIVE TOLBUTamide [Presence] in Specimen   MIN DefinitionDescription                   DRUG/TOX   48321-4         Both       0 TOLBUTamide Spec Ql       N   DRUG/TOXICOLOGY; Drugs; Misc; Miscellaneous; Novo-butamide; Ordinal; Orinase; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified 2.69 2.21                     The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
48322-2 acetoHEXAMIDE PrThr XXX Pt Ord     ACTIVE Acetohexamide [Presence] in Specimen   MIN DefinitionDescription                   DRUG/TOX   48322-2         Both       0 acetoHEXAMIDE Spec Ql       N   DRUG/TOXICOLOGY; Drugs; Dymelor; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified 2.69 2.21                     The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
48323-0 TOLAZamide PrThr XXX Pt Ord     ACTIVE TOLAZamide [Presence] in Specimen   MIN DefinitionDescription                   DRUG/TOX   48323-0         Both       0 TOLAZamide Spec Ql       N   DRUG/TOXICOLOGY; Drugs; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Tolinase; Unspecified 2.69 2.21                     The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
48324-8 chlorproPAMIDE PrThr XXX Pt Ord     ACTIVE chlorproPAMIDE [Presence] in Specimen   MIN DefinitionDescription                   DRUG/TOX   48324-8         Both       0 chlorproPAMIDE Spec Ql       N   Diabinese; DRUG/TOXICOLOGY; Drugs; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified 2.69 2.21                     The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
48325-5 Glimepiride PrThr Ser/Plas Pt Ord     ACTIVE Glimepride [Presence] in Serum or Plasma   MIN DefinitionDescription       None detected           DRUG/TOX   48325-5         Both       0 Glimepiride SerPl Ql       N   Amaryl; DRUG/TOXICOLOGY; Drugs; Glista OD; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.73 2.21                     The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
104,672 results found